New Delhi[India], Nov 16 (ANI) Indian government is in dialogue with US biotech giant Moderna, regarding initial successful development of its COVID-19 vaccine candidate, which the drugmaker on Monday announced had achieved 94.5 per cent efficacy in phase 3 trials.
Washington DC [US], November 16 (ANI): US Vice President-elect Kamala Harris on Monday said that Joe Biden's administration would get COVID-19 under control in the country which has crossed the 11 million mark.
Geneva [Switzerland], November 16 (ANI/Sputnik): The World Health Organization (WHO) is encouraged to hear the announcement of the US biotech firm, Moderna, about the efficacy results of its coronavirus vaccine during its phase three clinical trials, its press office said on Monday.
Washington DC [US], November 16 (ANI): US President Donald Trump on Monday was quick to take credit as Moderna announced that its Covid-19 vaccine candidate has shown nearly 95 per cent efficacy.
Washington DC [US], November 16 (ANI): After the US biotech company Moderna on Monday announced significant interim results of its Covid-19 vaccine, the White House credited US President Donald Trump for the progress of the vaccine which has been shown to be 94.5 per cent effective for the t
Massachusetts [US], November 16 (ANI): US biotech company Moderna on Monday announced a new potential Covid-19 vaccine, which has been shown to be 94.5 per cent effective at protecting people from coronavirus, according to interim results from late-stage clinical trials.
Washington [US], November 12 (ANI): Moderna expects to have an announcement on the efficacy of its COVID-19 vaccine after it finished accumulating data for a first analysis of the vaccine, the company said in a statement on Wednesday.
Washington [US], August 12 (ANI): The United States has made an agreement with the pharmaceutical company Moderna to deliver 100 million doses of their novel coronavirus vaccine once it becomes available, said President Donald Trump on Tuesday.
Washington D.C. [US], July 31 (Sputnik/ANI): The United States vaccinated several hundred volunteers during the first days of two Phase 3 COVID-19 vaccine trials, senior administration official told reporters.
Washington [US], July 15 (ANI): US drugmaker Moderna's shares soared by more than 16 per cent after the company said its potential vaccine to prevent Covid-19 produced a "robust" immune response in all 45 patients in its early stage human trial, CNBC reported.
Beijing [China], May 23 (ANI): Days after US drugmaker Moderna announced Phase one trial of its COVID-19 vaccine has shown positive results, researchers on Friday reported that a vaccine developed in China appears to be safe and may protect people from the deadly virus.
Washington D.C. [US], May 19 (ANI): As the scientists across the world are struggling to develop a vaccine for combating coronavirus, US drugmaker Moderna announced on Monday (local time) that the phase I trial of its Covid-19 vaccine has shown positive early results.